PharmaBoardroom

Interview with Young-Jin Kim, CEO, Handok

Please introduce Handok Pharmaceuticals to our readers, and in particular how it has evolved through partnerships with different multinational…

Interview with Leo Van Der Geer, President & CEO, Solvay…

You have led a successful career within the Solvay Group in various European countries. Looking back at all these international assignments, including…

Interview with Jürgen Fritze, Head of Medical Affairs, PKV

As part of the PKV – the German Association of Private Health Insurance – could you briefly introduce to our readers the German private health…

Interview with Angela Trismitro , President Director, Dos Ni Roha

Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in…

Interview with Guido Rasi, General Director, AIFA

When you were appointed General Director of the Agenzia Italiana del Farmaco (AIFA) in 2007, the dedicated Investigation Commission highlighted the…

Interview with Fabrice Baschiera, General Manager, Sanofi Aventis…

You have been in S. Korea for a little over a year, following international assignments in Vietnam and Thailand. Besides the fact that this is a much…

Interview with Silvio Gherardi, President, Baxter Italy

Following 20 years of a comprehensive experience in diverse fields of the pharmaceutical industry, you entered Baxter in 2000. At the time, the…

Interview with Michael Pehl, Managing Director, Celgene Germany

Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006?…

Interview with Jurgen Konig, President / Representative Director,…

You have been in South Korea for several months, following some time as Merck’s President in Pakistan. In your opinion, what do you find as the…

Interview with Fred Park, Country Manager, Cegedim Dendrite South…

You have been working in the CRM industry, particularly with pharmaceutical companies, for more then 10 years. Could you briefly introduce to our…

Interview with Andrew Eve, President Director, Boehringer…

After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry?…

Interview with Ulrich Behrendt, President, VBU

Could you briefly present the Association of German Biotechnology Companies (VBU) and DECHEMA e.V. to our readers and describe their importance to the…

Tagged with